Skip to main content
SpringerLink
Log in

Misuse of Methylphenidate

  • Chapter
  • First Online:
Non-medical and illicit use of psychoactive drugs

Part of the book series: Current Topics in Behavioral Neurosciences ((CTBN,volume 34))

Abstract

This chapter reviews methylphenidate misuse, abuse, dependence, diversion, and malingering associated with its use as a prescription medication for attention-deficit/hyperactivity disorder and the nonmedical use linked to its stimulant effects. Methylphenidate-induced regional elevations in brain dopamine appear to be integral to both efficacy in attention-deficit/hyperactivity disorder and potential for abuse, raising potential concerns for drug safety and prescription drug diversion costs associated with nonmedical use. Regardless, methylphenidate is an important treatment option, and detecting malingering for the purpose of illicit access to methylphenidate for subsequent misuse or diversion is a difficult challenge. Also discussed are the effects of methylphenidate in patients with comorbid substance use disorder and the potential linkage of methylphenidate use with subsequent substance abuse. The current data suggest that methylphenidate misuse and diversion are common health-care problems with a stimulant prescription drug diversion prevalence of approximately 5–10 % of high school students and 5–35 % of college students. The effectiveness and speed of action of methylphenidate are deemed desirable to enhance attention and focus performance for activities such as studying for exams, but methylphenidate is also misused recreationally. These data suggest a need for close screening and therapeutic monitoring of methylphenidate use in the treatment of attention-deficit/hyperactivity disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Advokat C, Lane SM, Luo C (2011) College students with and without ADHD: comparison of self-report of medication usage, study habits, and academic achievement. J Attn Disord 15(8):656–666

    Article  Google Scholar 

  • Aldridge AP, Kroutil LA, Cowell AJ et al (2011) Medication costs to private insurers of diversion of medications for attention-deficit hyperactivity disorder. Pharmacoeconomics 29(7):621–635

    PubMed  Google Scholar 

  • American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Publishing, Arlington

    Book  Google Scholar 

  • Andersen SL, Arvanitogiannis A, Pliakas AM et al (2002) Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nat Neurosci 5(1):13–14

    Article  CAS  PubMed  Google Scholar 

  • Arias AJ, Gelernter J, Chan G et al (2008) Correlates of co-occurring ADHD in drug-dependent subjects: prevalence and features of substance dependence and psychiatric disorders. Addict Behav 33(9):1199–1207

    Article  PubMed  PubMed Central  Google Scholar 

  • Arnsten AFT (2011) Catecholamine influences on dorsolateral prefrontal cortical networks. Biol Psychiatry 69(12):e89–e99

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Arnsten AFT, Li BM (2005) Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry 57(11):1377–1384

    Article  CAS  PubMed  Google Scholar 

  • Arnsten AFT, Rubia K (2012) Neurobiological circuits regulating attention, cognitive control, motivation, and emotion: disruptions in neurodevelopmental psychiatric disorders. J Am Acad Child Adolesc Psychiatry 51(4):356–367

    Article  PubMed  Google Scholar 

  • Barkley RA, Fischer M, Smallish L et al (2003) Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study. Pediatrics 111(1):97–109

    Article  PubMed  Google Scholar 

  • Barrett SP, Darredeau C, Bordy LE et al (2005) Characteristics of methylphenidate misuse in a university student sample. Can J Psychiatry 50(8):457–461

    Article  PubMed  Google Scholar 

  • Berman SM, Kuczenski R, McCracken JT et al (2009) Potential adverse effects of amphetamine treatment on brain and behavior: a review (published correction appears in Mol Psychiatry. 2010;15(11):1121). Mol Psychiatry 14(2):123–142

    Article  CAS  PubMed  Google Scholar 

  • Biederman J (2005) Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatry 57(11):1215–1220

    Article  PubMed  Google Scholar 

  • Biederman J, Faraone SV, Mick E et al (1995) High risk for attention deficit hyperactivity disorder among children of parents with childhood onset of the disorder: a pilot study. Am J Psychiatry 152(3):431–435

    Article  CAS  PubMed  Google Scholar 

  • Biederman J, Monuteaux MC, Spencer T et al (2008) Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. Am J Psychiatry 165(5):597–603

    Article  PubMed  Google Scholar 

  • Biederman J, Spencer TJ, Monuteaux MC et al (2010) A naturalistic 10-year prospective study of height and weight in children with attention-deficit hyperactivity disorder grown up: sex and treatment effects. J Pediatr 157:635–640

    Article  PubMed  PubMed Central  Google Scholar 

  • Biederman J, Wilens T, Mick E et al (1997) Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 36(1):21–29

    Article  CAS  PubMed  Google Scholar 

  • Biederman J, Wilens T, Mick E et al (1999) Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics 104(2):e20

    Article  CAS  PubMed  Google Scholar 

  • Bloom B, Jones LI, Freeman G (2013) Summary health statistics for U.S. children: national health interview survey, 2012. National center for health statistics. Vital Health Stat 10(258)

    Google Scholar 

  • Bogle KE, Smith BH (2009) Illicit methylphenidate use: a review of prevalence, availability, pharmacology, and consequences. Curr Drug Abuse Rev 2(2):157–176

    Article  PubMed  Google Scholar 

  • Booksh R, Pella RD, Singh AN et al (2010) Ability of college students to simulate ADHD on objective measures of attention. J Atten Disord 13(4):325–338

    Article  Google Scholar 

  • Brandon CL, Marinelli M, White FJ (2003) Adolescent exposure to methylphenidate alters the activity of rat midbrain dopamine neurons. Biol Psychiatry 54(12):1338–1344

    Article  CAS  PubMed  Google Scholar 

  • Bredeloux P, Dubuc I, Costentin J (2007) Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission. Br J Pharmacol 150(6):711–719

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bright GM (2008) Abuse of medications employed for the treatment of ADHD: results from a large-scale community survey. Medscape J Med 10(5):111

    PubMed  PubMed Central  Google Scholar 

  • Bymaster FP, Katner JS, Nelson DL et al (2002) Atomoxetine increases extracellular levels of norepinephrine and dopamine in the prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27(5):699–711

    Article  CAS  PubMed  Google Scholar 

  • Carlezon WA Jr, Mague SD, Andersen SL (2003) Enduring behavioral effects of early exposure to methylphenidate in rats. Biol Psychiatry 54(12):1330–1337

    Article  CAS  PubMed  Google Scholar 

  • Carlson GA, Kelly KL (2003) Stimulant rebound: how common is it and what does it mean? J Child Adolesc Psychopharmacol 13(2):137–142

    Article  PubMed  Google Scholar 

  • Cascade E, Kalali AH, Weisler RH et al (2008) Seasonality and the changing adult/child prescription ratios in ADHD therapy. Psychiatry (Edgmont) 5(1):23–25

    Google Scholar 

  • Cepeda MS, Fife D, Berwaerts J et al (2014) Shopping behavior for ADHD drugs: results of a cohort study in a pharmacy database. Drugs R D 14(3):205–211

    Article  PubMed  PubMed Central  Google Scholar 

  • Center for Medicare and Medicaid Services (2012) Drug diversion in the medicaid program: state strategies for reducing prescription drug diversion in medicaid. United States Department of Health and Human Services, Baltimore. http://www.cms.gov/Medicare-Medicaid-Coordination/Fraud-Prevention/MedicaidIntegrityProgram/downloads/drugdiversion.pdf. Accessed 26 Aug 2014

  • Charach A, Yeung E, Climans T et al (2011) Childhood attention-deficit/hyperactivity disorder and future substance use disorders: comparative meta-analyses. J Am Acad Child Adolesc Psychiatry 50(1):9–21

    Article  PubMed  Google Scholar 

  • Chen LY, Strain EC, Alexandre PK et al (2014) Correlates of nonmedical use of stimulants and methamphetamine use in a national sample. Addict Behav 39(5):829–836

    Article  PubMed  PubMed Central  Google Scholar 

  • Christensen L, Sansané R, Hodgkins P et al (2010) Pharmacological treatment patterns among patients with attention-deicit/hyperactivity disorder: retrospective claims-based analysis of a managed care population. CMRO 26(4):977–989

    CAS  Google Scholar 

  • Clemow DB, Walker DJ (2014) The potential for misuse and abuse of medications in ADHD: a review. Postgrad Med 126(5):64–81

    Article  PubMed  Google Scholar 

  • Cohen AL, Jhung MA, Budnitz DS (2006) Stimulant medications and attention deficit-hyperactivity disorder. N Engl J Med 354(21):2294–2295

    Article  CAS  PubMed  Google Scholar 

  • Concerta Package Insert (2010) McNeil Pediatrics, Titusville

    Google Scholar 

  • Cooper WO, Habel LA, Sox CM et al (2011) ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med 365:1896–1904

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cortese S, Holtmann M, Banaschewski T et al (2013) European ADHD guidelines group. Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. J Child Psychol Psychiatry 54(3):227–246

    Article  PubMed  Google Scholar 

  • Dalsgaard S, Mortensen PB, Frydenberg M et al (2014) ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood—a naturalistic long-term follow-up study. Addict Behav 39(1):325–328

    Article  PubMed  Google Scholar 

  • Darredeau C, Barrett SP, Jardin B et al (2007) Patterns and predictors of medication compliance, diversion, and misuse in adult prescribed methylphenidate users. Hum Psychopharmacol 22(8):529–536

    Article  PubMed  Google Scholar 

  • Del Campo N, Chamberlain SR, Sahakian BJ et al (2011) The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biol Psychiatry 69(12):e145–157

    Google Scholar 

  • Doremus-Fitzwater TL, Varlinskaya EI, Spear LP (2010) Motivational systems in adolescence: possible implications for age differences in substance abuse and other risk-taking behaviors. Brain Cogn 72(1):114–123

    Article  PubMed  Google Scholar 

  • Dupont RL, Coleman JJ, Bucher RH et al (2008) Characteristics and motives of college students who engage in nonmedical use of methylphenidate. Am J Addict 17(3):167–171

    Article  PubMed  Google Scholar 

  • Economidou D, Dalley JW, Everitt BJ (2011) Selective norepinephrine reuptake inhibition by atomoxetine prevents cue-induced heroin and cocaine seeking. Biol Psychiatry 69(3):266–274

    Article  CAS  PubMed  Google Scholar 

  • Faraone SV, Biederman J, Morley CP et al (2008) Effect of stimulants on height and weight: a review of the literature. J Am Acad Child Adolesc Psychiatry 47:994–1009

    PubMed  Google Scholar 

  • Fayyad J, De Graaf R, Kessler R et al (2007) Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 190:402–409

    Article  CAS  PubMed  Google Scholar 

  • Fuermaier AB, Tucha L, Koerts J et al (2012) Measurement of stigmatization towards adults with attention deficit hyperactivity disorder 7(12):e51755

    Google Scholar 

  • Gasior M, Bergman J, Kallman MJ et al (2005) Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys. Neuropsychopharmacology 30(4):758–764

    CAS  PubMed  Google Scholar 

  • Gamo NJ, Wang M, Arnsten AFT (2010) Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors. J Am Acad Child Adolesc Psychiatry 49(10):1011–1023

    Article  PubMed  PubMed Central  Google Scholar 

  • Groenman AP, Oosterlaan J, Rommelse NNJ et al (2013) Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder. Br J Psychiatry 203:112–119

    Article  PubMed  Google Scholar 

  • Habel LA, CooperWO Sox CM et al (2011) ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA 306:2673–2683

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Harp JP, Jasinski LJ, Shandera-Ochsner AL et al (2011) Detection of malingered ADHD using the MMPI-2-RF. Psychol Inj Law 4(1):32–43

    Article  Google Scholar 

  • Harrison AG, Edwards MJ, Parker KCH (2007) Identifying students faking ADHD: preliminary findings and strategies for detection. Arch Clin Neuropsychol 22(5):577–588

    Article  PubMed  Google Scholar 

  • Harstad E, Levy S, and Committee on Substance Abuse (2014) Attention-deficit/hyperactivity disorder and substance abuse. Pediatrics 134(1):e293–e301

    Article  PubMed  Google Scholar 

  • Heil SH, Holmes HW, Bickel WK et al (2002) Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users. Drug Alcohol Depend 67(2):149–156

    Article  CAS  PubMed  Google Scholar 

  • Hutcheson DM, Everitt BJ (2003) The effects of selective orbitofrontal cortex lesions on the acquisition and performance of cue-controlled cocaine seeking in rats. Ann N Y Acad Sci 1003:410–411

    Article  PubMed  Google Scholar 

  • Ito R, Dalley JW, Howes SR et al (2000) Dissociation in conditioned dopamine release in the nucleus accumbens core and shell in response to cocaine cues and during cocaine-seeking behavior in rats. J Neurosci 20(19):7489–7495

    CAS  PubMed  Google Scholar 

  • Ito R, Robbins TW, Everitt BJ (2004) Differential control over cocaine seeking behavior by nucleus accumbens core and shell. Nat Neurosci 7(4):389–397

    Article  CAS  PubMed  Google Scholar 

  • Intuniv Package Insert (2011) Shire Inc, Wayne

    Google Scholar 

  • Jachimowicz G, Geiselman RE (2004) Comparison of ease of falsification of attention deficit hyperactivity disorder diagnosis using standard behavioral rating scales. Cognitive Sci Online 2:6–20

    Google Scholar 

  • Jasinski DR, Faries DE, Moore RJ et al (2008) Abuse liability assessment of atomoxetine in a drug-abusing population. Drug Alcohol Depend 95(1–2):140–146

    Article  CAS  PubMed  Google Scholar 

  • Jasinski DR, Krishnan S (2009) Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse. J Psychopharmacol 23(4):419–427

    Article  CAS  PubMed  Google Scholar 

  • Jasinski LJ, Harp JP, Berry DTR et al (2011) Using symptom validity tests to detect malingered ADHD in college students. Clin Neuropsychol 25(8):1415–1428

    Article  PubMed  Google Scholar 

  • Joffe A (2014) Nonmedical use of prescription stimulants by adolescents. Adolesc Med 25(1):89–103

    Google Scholar 

  • Johnston LD, O’Malley PM, Bachman JG et al (2012) Monitoring the future: national survey results on drug use, 1975–2011: vol II, college students and adults ages 19–50. Institute for Social Research, The University of Michigan, Ann Arbor. http://www.monitoringthefuture.org/pubs/monographs/mtf-vol2_2011.pdf. Accessed 26 Aug 2014

  • Johnston LD, O’Malley PM, Bachman JG et al (2014) Monitoring the future: national survey results on drug use, 1975–2013: vol I, secondary school students. Institute for Social Research, The University of Michigan, Ann Arbor. http://www.monitoringthefuture.org/pubs/monographs/mtf-vol1_2012.pdf. Accessed 26 Aug 2014

  • Jordan CJ, Harvey RC, Baskin BB et al (2014) Cocaine-seeking behavior in a genetic model of attention-deficit/hyperactivity disorder following adolescent methylphenidate or atomoxetine treatments. Drug Alcohol Depend 140:25–32

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kahlig KM, Binda F, Khoshbouei H et al (2005) Amphetamine induces dopamine efflux through a dopamine transporter channel. Proc Natl Acad Sci U S A 102(9):3495–3500

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kapvay Package Insert (2010) Shionogi Pharma Inc, Florham Park

    Google Scholar 

  • Katusic SK, Barbaresi WJ, Colligan RC et al (2005) Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit/hyperactivity disorder: a population-based, birth cohort study. J Child Adolesc Psychopharmacol 15(5):764–776

    Google Scholar 

  • Katzman MA, Sternat T (2014) A review of OROS methylphenidate (Concerta®) in the treatment of attention-deficit/hyperactivity disorder. CNS Drugs 28:1005–1033

    Article  CAS  PubMed  Google Scholar 

  • Kawaura K, Karasawa J, Chaki S et al (2014) Stimulation of postsynapse adrenergic α2a receptor improves attention/cognition performance in an animal model of attention deficit hyperactivity disorder. Behav Brain Res 270:349–356

    Article  CAS  PubMed  Google Scholar 

  • Kessler RC, Adler LA, Barkley R et al (2005) Patterns and predictors of ADHD persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry 57(11):1442–1451

    Article  PubMed  PubMed Central  Google Scholar 

  • Kessler RC, Adler L, Barkley R et al (2006) The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity survey replication. Am J Psychiatry 163(4):716–723

    Article  PubMed  PubMed Central  Google Scholar 

  • Klein-Schwartz W, McGrath J (2003) Poison centers’ experience with methylphenidate abuse in pre-teens and adolescents. J Am Acad Child Adolesc Psychiatry 42(3):288–294

    Article  PubMed  Google Scholar 

  • Koda K, Ago Y, Cong Y et al (2010) Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice. J Neurochem 114(1):259–270

    CAS  PubMed  Google Scholar 

  • Kollins SH (2003) Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient. J Clin Psychiatry 64(Suppl 11):14–18

    CAS  PubMed  Google Scholar 

  • Kollins SH (2007) Abuse liability of medications used to treat attention-deficit/hyperactivity disorder (ADHD). Am J Addict 16(Suppl 1):35–42

    Article  PubMed  Google Scholar 

  • Kollins SH, English J, Robinson R et al (2009) Reinforcing and subjective effects of methylphenidate in adults with and without attention deficit hyperactivity disorder (ADHD). Psychopharmacology 204(1):73–83

    Article  CAS  PubMed  Google Scholar 

  • Kroutil LA, Van Brunt DL, Herman-Stahl MA et al (2006) Nonmedical use of prescription stimulants in the United States. Drug Alcohol Depend 84(2):135–143

    Article  PubMed  Google Scholar 

  • Kuczenski R, Segal DS (1997) Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J Neurochem 68(5):2032–2037

    Article  CAS  PubMed  Google Scholar 

  • Lee SS, Humphreys KL, Flory K et al (2011) Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev 31(3):328–341

    Article  PubMed  PubMed Central  Google Scholar 

  • Lensing MB, Zainer P, Sandvik L et al (2013) Adults with ADHD: use and misuse of stimulant medication as reported by patients and their primary care physicians. Atten Defic Hyperact Disord 5(4):369–376

    Article  PubMed  Google Scholar 

  • Lile JA, Stoops WW, Durell TM et al (2006) Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans. Exp Clin Psychopharmacol 14(2):136–147

    Article  CAS  PubMed  Google Scholar 

  • Mao AR, Babcock T, Brams M (2011) ADHD in adults: current treatment trends with consideration of abuse potential of medications. J Psychiatr Pract 17(4):241–250

    Article  PubMed  Google Scholar 

  • Mannuzza S, Klein RG, Truong NL et al (2008) Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood. Am J Psychiatry 165(5):604–609

    Article  PubMed  PubMed Central  Google Scholar 

  • Marshall P, Schroeder R, O’Brien J et al (2010) Effectiveness of symptom validity measures in identifying cognitive and behavioral symptom exaggeration in adult attention deficit hyperactivity disorder. Clin Neuropsychol 24(7):1204–1237

    Article  PubMed  Google Scholar 

  • McCabe SE, Teter CJ, Boyd CJ (2004a) The use, misuse and diversion of prescription stimulants among middle and high school students. Subst Use Misuse 39(7):1095–1116

    Article  PubMed  Google Scholar 

  • McCabe SE, Teter CJ, Boyd CJ et al (2004b) Prevalence and correlates of illicit methylphenidate use among 8th, 10th, and 12th grade students in the United States, 2001. J Adolesc Health 35(6):501–504

    Google Scholar 

  • McCabe SE, Knight JR, Teter CJ et al (2005) Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey (published corrections appears in Addiction. 2005; 100(4):573). Addiction 100(1):96–106

    Article  PubMed  Google Scholar 

  • McCabe SE, Boyd CJ, Teter CJ (2006a) Medical use, illicit use, and diversion of abusable prescription drugs. J Am Coll Health 54(5):269–278

    Article  PubMed  PubMed Central  Google Scholar 

  • McCabe SE, Teter CJ, Boyd CJ (2006b) Medical use, illicit use and diversion of prescription stimulant medication. J Psychoactive Drugs 38(1):43–56

    Article  PubMed  PubMed Central  Google Scholar 

  • McCabe SE, West BT (2013) Medical and nonmedical use of prescription stimulants: results from a national multicohort study. J Am Acad Child Adolesc Psychiatry 52(12):1272–1280

    Article  PubMed  PubMed Central  Google Scholar 

  • McCabe SE, West BT, Teter CJ et al (2014) Trends in medical use, diversion, and nonmedical use of prescription medications among college students from 2003 to 2013: connecting the dots. Addict Behav 39:1176–1182

    Article  PubMed  PubMed Central  Google Scholar 

  • Merkel RL, Kuchibhatla A (2009) Safety of stimulant treatment in attention deficit hyperactivity disorder: part 1. Expert Opin Drug Saf 8(6):655–668

    Article  CAS  PubMed  Google Scholar 

  • Messina BG, Silvestri MM, Diulio AR et al (2014) Alcohol use, impulsivity, and the non-medical use of prescription stimulants among college students. Addict Behavior 39:1798–1803

    Article  Google Scholar 

  • Molina BSG, Pelham WE Jr (2003) Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Psychol 112(3):497–507

    Article  PubMed  Google Scholar 

  • Murnane KS, Howell LL (2011) Neuroimaging and drug taking in primates. Psychopharmacology 216(2):153–171

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Musso MW, Hill BD, barker AA et al (2014) Utility of the personality assessment inventory for detecting malingered ADHD in college students. J Attention Disord. doi:10.1177/1087054714548031 (Epub ahead of print 9 September 2014)

  • Musso MW, Gouvier WD (2014) “Why is this so hard?” A review of detection of malingered ADHD in college students. J Attention Discord 18(3):186–201

    Article  Google Scholar 

  • National Institute on Drug Abuse (2011) Commonly abused prescription drugs. http://www.drugabuse.gov/sites/default/files/rx_drugs_placemat_508c_10052011.pdf. Accessed 19 Aug 2014

  • Novak SP, Kroutil LA, Williams RL et al (2007) The nonmedical use of prescription ADHD medications: results from a national internet panel. Subst Abuse Treat Prev Policy 2:32

    Article  PubMed  PubMed Central  Google Scholar 

  • Olfson M, Huang C, Gerhard T et al (2012) Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 51:147–156

    Article  PubMed  Google Scholar 

  • Parasrampuria DA, Schoedel KA, Schuller R et al (2007) Do formulation differences alter abuse liability of methylphenidate? A placebo-controlled, randomized, double-blind, crossover study in recreational drug users. J Clin Psychopharmacol 27(5):459–467

    Article  CAS  PubMed  Google Scholar 

  • Poulin C (2001) Medical and nonmedical stimulant use among adolescents: from sanctioned to unsanctioned use. CMAJ 165(8):1039–1044

    CAS  PubMed  PubMed Central  Google Scholar 

  • Poulin C (2007) From attention-deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non-medical stimulant use: connecting the dots. Addiction 102(5):740–751

    Article  PubMed  Google Scholar 

  • Quinn CA (2003) Detection of malingering in assessment of adult ADHD. Arch Clin Neuropsychol 18(4):379–395

    Article  PubMed  Google Scholar 

  • Rabiner DL (2013) Stimulant prescription cautions: addressing misuse, diversion, and malingering. Curr Psychiatry Rep 15(7):375

    Article  PubMed  Google Scholar 

  • Rabiner DL, Anastopoulos AD, Costello EJ et al (2009a) Motives and perceived consequences of nonmedical ADHD medication use by college students: are students treating themselves for attention problems? J Attent Disord 13(3):259–270

    Article  Google Scholar 

  • Rabiner DL, Anastopoulos AD, Costello EJ et al (2009b) The misuse and diversion of prescribed ADHD medications by college students. J Atten Disord 13(2):144–153

    Article  PubMed  Google Scholar 

  • Rowlett JK, Platt DM, Yao WD et al (2007) Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys. J Pharmacol Exp Ther 321(3):1135–1143

    Article  CAS  PubMed  Google Scholar 

  • Rush CR, Essman WD, Simpson CA et al (2001) Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing humans. J Clin Psychopharmacol 21(3):273–286

    Article  CAS  PubMed  Google Scholar 

  • Sansone RA, Sansone LA (2011) Faking attention deficit hyperactivity disorder. Innov Clin Neurosci 8(8):10–13

    Google Scholar 

  • Sclar DA, Robison LM, Castillo LV et al (2012) Attention deficit/hyperactivity disorder among adults in the US: trend in diagnosis and use of pharmacotherapy. Pharmaceut Med 26(2):97–101

    Google Scholar 

  • Sepúlveda DR, Thomas LM, McCabe SE et al (2011) Misuse of prescribed stimulant medication for ADHD and associated patterns of substance use: preliminary analysis among college students. J Pharm Pract 24(6):551–560

    Article  PubMed  PubMed Central  Google Scholar 

  • Schenk S, Izenwasser S (2002) Pretreatment with methylphenidate sensitizes rats to the reinforcing effects of cocaine. Pharmacol Biochem Behav 72(3):651–657

    Article  CAS  PubMed  Google Scholar 

  • Schneider BN, Enenbach M (2014) Managing the risks of ADHD treatments. Curr Psychiatry Rep 16(10):479

    Article  PubMed  Google Scholar 

  • Schramm-Sapyta NL, Cha YM, Chaudhry S (2007) Differential anxiogenic, aversive, and locomotor effects of THC in adolescent and adult rats. Psychopharmacology 191(4):867–877

    Article  CAS  PubMed  Google Scholar 

  • Simpson D, Plosker GL (2004) Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder. Drugs 64(2):205–222

    Article  CAS  PubMed  Google Scholar 

  • Sollman MJ, Ranseen JD, Berry DTR (2010) Detection of feigned ADHD in college students. Psychol Assess 22(2):325–335

    Article  PubMed  Google Scholar 

  • Somkuwar SS, Jordan CJ, Kantak KM et al (2013) Adolescent atomoxetine treatment in a rodent model of ADHD: effects on cocaine self-administration and dopamine transporters in frontostriatal regions. Neuropsychopharmacology 38(13):2588–2597

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sopko MA Jr, Caberwal H, Chavez B (2010) The safety and efficacy of methylphenidate and dexmethylphenidate in adults with attention deficit/hyperactivity disorder. J Cent Nerv Syst Dis 2:15–30

    CAS  PubMed  PubMed Central  Google Scholar 

  • Spencer TJ, Biederman J, Ciccone PE et al (2006) PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate. Am J Psychiatry 163(3):387–395

    Article  PubMed  Google Scholar 

  • Stahl SM (2003a) Neurotransmission of cognition, part 1, dopamine is a hitchhiker in frontal cortex: norepinephrine transporters regulate dopamine. J Clin Psychiatry 64(1):4–5

    Article  PubMed  Google Scholar 

  • Stahl SM (2003b) Neurotransmission of cognition, part 2. Selective NRIs are smart drugs: exploiting regionally selective actions on both dopamine and norepinephrine to enhance cognition. J Clin Psychiatry 64(2):110–111

    Article  PubMed  Google Scholar 

  • Stahl SM (2003c) Neurotransmission of cognition, part 3. Mechanism of action of selective NRIs: both dopamine and norepinephrine increase in prefrontal cortex. J Clin Psychiatry 64(3):230–231

    Article  PubMed  Google Scholar 

  • Stahl SM (2008) Stahl’s essential psychopharmacology: neuroscientific basis and practical application, 3rd edn. Cambridge University Press, New York

    Google Scholar 

  • Stoops WW, Glaser PEA, Fillmore MT et al (2004) Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans. J Psychopharmacol 18(4):534–543

    Article  CAS  PubMed  Google Scholar 

  • Stoops WW, Lile JA, Fillmore MT et al (2005) Reinforcing effects of methylphenidate: influence of dose and behavioral demands following drug administration. Psychopharmacol 177:349–355

    Article  CAS  Google Scholar 

  • Strattera Package Insert (2014) Eli Lilly and Company, Indianapolis

    Google Scholar 

  • Substance Abuse and Mental Health Services Administration (2001) Treatment for stimulant use disorders. Center for Substance Abuse Treatment, US Department of Health and Human Services, Rockville. https://store.samhsa.gov/shin/content/QGCT33/QGCT33.pdf. Accessed 26 Aug 2014

  • Substance Abuse and Mental Health Services Administration (2007) Results from the 2006 national survey on drug use and health: national findings. Office of Applied Studies, US Department of Health and Human Services, Rockville. https://www.asipp.org/documents/2006NSDUH.pdf. Accessed 26 Aug 2014

  • Substance Abuse and Mental Health Services Administration (2013) The DAWN report: emergency department visits involving attention deficit/hyperactivity disorder stimulant medications. Center for Behavioral Health Statistics and Quality, Rockville. http://www.samhsa.gov/data/2k13/dawn073/sr073-add-adhd-medications.htm. Accessed 26 Aug 2014

  • Suhr J, Hammers D, Dobbins-Buckland K et al (2008) The relationship of malingering test failure to self-reported symptoms and neuropsychological findings in adults referred for ADHD evaluation. Arch Clin Neuropsychol 23(5):521–530

    Article  PubMed  Google Scholar 

  • Suhr JA, Sullivan BK, Rodriguez JL (2011) The relationship of noncredible performance to continuous performance test scores in adults referred for attention-deficit/hyperactivity disorder evaluation. Arch Clin Neuropsychol 26(1):1–7

    Article  PubMed  Google Scholar 

  • Sullivan BK, May K, Galbally L (2007) Symptom exaggeration by college adults in attention-deficit hyperactivity disorder and learning disorder assessments. Appl Neuropsychol 14(3):189–207

    Article  PubMed  Google Scholar 

  • Sweeney CT, Sembower MA, Ertischek MD et al (2013) Nonmedical use of prescription ADHD stimulants and preexisting patterns of drug abuse. J Addict Dis 32(1):1–10

    Article  PubMed  PubMed Central  Google Scholar 

  • Teter CJ, McCabe SE, Boyd CJ et al (2003) Illicit methylphenidate use in an undergraduate student sample: prevalence and risk factors. Pharmacotherapy 23(5):609–617

    Article  PubMed  Google Scholar 

  • Teter CJ, McCabe SE, Cranford JA et al (2005) Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample. J Am Coll Health 53(6):253–262

    Article  PubMed  Google Scholar 

  • Teter CJ, McCabe SE, LaGrange K et al (2006) Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy 26(10):1501–1510

    Article  PubMed  PubMed Central  Google Scholar 

  • Tucha L, Sontag TA, Walitza S et al (2009) Detection of malingered attention deficit hyperactivity disorder. Atten Defic Hyperact Disord 1(1):47–53

    Google Scholar 

  • Upadhyaya HP (2007) Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder. J Clin Psychiatry 68(Suppl 11):23–30

    CAS  PubMed  Google Scholar 

  • Upadhyaya HP, Kroutil LA, Deas D et al (2010) Stimulant formulation and motivation for nonmedical use of prescription attention-deficit/hyperactivity disorder medications in a college-aged population. Am J Addict 19(6):569–577

    Article  PubMed  Google Scholar 

  • Upadhyaya HP, Rose K, Wang W et al (2005) Attention-deficit/hyperactivity disorder, medication treatment, and substance use patterns among adolescents and young adults. J Child Adolesc Psychopharmacol 15(5):799–809

    Article  PubMed  Google Scholar 

  • Volkow ND, Swanson JM (2003) Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry 160(11):1909–1918

    Article  PubMed  Google Scholar 

  • Volkow ND, Wang GJ, Fischman MW et al (1997) Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386(6627):827–830

    Article  CAS  PubMed  Google Scholar 

  • Volkow ND, Wang GJ, Kollins SH et al (2009) Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA 302(10):1084–1091

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Volkow ND, Wang GJ, Newcorn J et al (2007a) Brain dopamine transporter levels in treatment and drug naïve adults with ADHD. Neuroimage 34(3):1182–1190

    Article  PubMed  Google Scholar 

  • Volkow ND, Wang GJ, Newcorn J et al (2007b) Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 64(8):932–940

    Article  CAS  PubMed  Google Scholar 

  • Wee S, Woolverton WL (2004) Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine. Drug Alcohol Depend 75(3):271–276

    Article  CAS  PubMed  Google Scholar 

  • Weiss M, Murray C (2003) Assessment and management of attention-deficit hyperactivity disorder in adults. CMAJ 168(6):715–722

    PubMed  PubMed Central  Google Scholar 

  • Wetzell BB, Muller MM, Cobuzzi JL et al (2014) Effect of age on methylphenidate-induced conditioned taste avoidance and related BDNF/TrkB signaling in the insular cortex of the rat. Psychopharmacology 231(8):1493–1501

    Article  CAS  PubMed  Google Scholar 

  • Whitelaw RB, Markou A, Robbins TW et al (1996) Excitotoxic lesions of the basolateral amygdala impair the acquisition of cocaine-seeking behaviour under a second-order schedule of reinforcement. Psychopharmacology 127(3):213–224

    Article  CAS  PubMed  Google Scholar 

  • Wilens TE, Adamson J, Monuteaux MC et al (2008a) Impact of prior stimulant treatment for attention-deficit hyperactivity disorder in the subsequent risk for cigarette smoking, alcohol, and drug use disorders in adolescent girls. Arch Pediatr Adolesc Med 162(10):916–921

    Article  PubMed  PubMed Central  Google Scholar 

  • Wilens TE, Adler LA, Adams J et al (2008b) Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry 47(1):21–31

    Article  PubMed  Google Scholar 

  • Wilens TE, Faraone SV, Biederman J et al (2003) Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 111(1):179–185

    Article  PubMed  Google Scholar 

  • Wilens TE, Gignac M, Swezey A et al (2006) Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications. J Am Acad Child Adolesc Psychiatry 45(4):408–414

    Article  PubMed  Google Scholar 

  • Wilens TE, Martelon M, Joshi G et al (2011) Does ADHD predict substance use disorders? A 10-year follow-up study of young adults with ADHD. J Am Acad Child Adolesc Psychiatry 50(6):543–553

    Article  PubMed  PubMed Central  Google Scholar 

  • Wilens TE, Morrison NR (2012) Substance-use disorders in adolescents and adults with ADHD: focus on treatment. Neuropsychiatry (London) 2(4):301–312

    Article  Google Scholar 

  • Wilson JJ, Levin FR (2005) Attention-deficit/hyperactivity disorder and early-onset substance use disorders. J Child Adolesc Psychopharmacol 15(5):751–763

    Article  PubMed  Google Scholar 

  • Young CJ, Gross AM (2011) Detection of response bias and noncredible performance in adult attention-deficit/hyperactivity disorder. Arch Clin Neuropsychol 26(3):165–175

    Article  PubMed  Google Scholar 

  • Zuvekas SH, Vitiello B (2012) Stimulant medication use among U.S. children: a 12-year perspective. Am J Psychiatry 169(2):160–166

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Senior Clinical Research Scientist, Lilly Corporate Center, 46285, Indianapolis, IN, USA

    David B. Clemow

Authors
  1. David B. Clemow
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David B. Clemow .

Editor information

Editors and Affiliations

  1. National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales, Australia

    Suzanne Nielsen

  2. University of Tasmania School of Psychology, Launceston, Tasmania, Australia

    Raimondo Bruno

  3. Victoria University of Wellington School of Psychology, Wellington, New Zealand

    Susan Schenk

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Clemow, D.B. (2015). Misuse of Methylphenidate. In: Nielsen, S., Bruno, R., Schenk, S. (eds) Non-medical and illicit use of psychoactive drugs. Current Topics in Behavioral Neurosciences, vol 34. Springer, Cham. https://doi.org/10.1007/7854_2015_426

Download citation

Publish with us

Policies and ethics

Search

Navigation